• 1
    Cuckle H, Benn P, Wright D. Down syndrome screening in the first and/or second trimester: model predicted performance using meta-analysis parameters. Semin Perinatol 2005; 29: 252257.
  • 2
    Cuckle H, Arbuzova S. Multianalyte Maternal Serum Screening for Chromosomal Defects. In Genetic Disorders and the Fetus: Diagnosis, Prevention and Treatment (5th edn), MilunskyA (ed). Johns Hopkins University Press: Baltimore, 2004.
  • 3
    Benn PA, Kaminsky LM, Ying J, Borgida AF, Egan JF. Combined second-trimester biochemical and ultrasound screening for Down syndrome. Obstet Gynecol 2002; 100: 11681176.
  • 4
    Benacerraf BR, Frigoletto FD Jr, Laboda LA. Sonographic diagnosis of Down syndrome in the second trimester. Am J Obstet Gynecol 1985; 153: 4952.
  • 5
    Cuckle HS, Wald NJ, Thompson SG. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol 1987; 94: 387402.
  • 6
    Souter VL, Nyberg DA, El-Bastawissi A, Zebelman A, Luthhardt F, Luthy DA. Correlation of ultrasound findings and biochemical markers in the second trimester of pregnancy in fetuses with trisomy 21. Prenat Diagn 2002; 22: 175182.
  • 7
    Bahado-Singh RO, Oz U, Hsu CD, Deren O, Copel JA, Mahoney MJ. Ratio of nuchal thickness to humerus length for Down syndrome detection. Am J Obstet Gynecol 2001; 184: 12841288.
  • 8
    Locatelli A, Piccoli MG, Vergani P, Mariani E, Ghidini A, Mariani S, Pezzullo JC. Critical appraisal of the use of nuchal fold thickness measurements for the prediction of Down syndrome. Am J Obstet Gynecol 2000; 182: 192197.
  • 9
    Borrell A, Costa D, Delgado RD, Martinez JM, Borrell C, Fortuny A. Interobserver variability of midtrimester fetal nuchal thickness. Eur J Obstet Gynecol Reprod Biol 1997; 72: 2729.
  • 10
    Wright D, Bradbury I, Cuckle H, Gardosi J, Tonks A, Standing S, Benn P. Three-stage contingent screening for Down syndrome. Prenat Diagn 2006; 26: 528534.
  • 11
    Benn PA, Fang M, Egan JFX, Horne D, Collins R. Incorporation of inhibin-A in second-trimester screening for Down syndrome. Obstet Gynecol 2003; 101: 451454.
  • 12
    Wald NJ, Huttly WJ, Hackshaw AK. Antenatal screening for Down's syndrome with the quadruple test. Lancet 2003; 361: 835836.
  • 13
    Fortuny A, Farre MT, Borrell A, Casals E, Mercade I, Seres A, Cararach V. Cribado bioquímico-ecográfico de aneuploidía fetal en el segundo trimestre de la gestación. Progr Obstet Ginecol 2004; 47: 257263.